Sanctuary Advisors’s Takeda Pharmaceutical TAK Stock Holding History

Sanctuary Advisors’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$591K	Buy	36,883 +7,426	+25%	+$123K	﹤0.01%	1852
2026 Q1	$546K	Buy	29,457 +5,831	+25%	+$102K	﹤0.01%	1723
2025 Q4	$368K	Buy	23,626 +912	+4%	+$13K	﹤0.01%	1895
2025 Q3	$333K	Buy	22,714 +1,227	+6%	+$18.2K	﹤0.01%	1941
2025 Q2	$332K	Buy	21,487 +236	+1%	+$3.49K	﹤0.01%	1852
2025 Q1	$316K	Sell	21,251 -8,200	-28%	-$115K	﹤0.01%	1761
2024 Q4	$403K	Sell	29,451 -40,570	-58%	-$557K	﹤0.01%	1822
2024 Q3	$937K	Buy	70,021 +35,161	+101%	+$499K	0.01%	1282
2024 Q2	$454K	Buy	+34,860	New	+$461K	﹤0.01%	1707

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Sanctuary Advisors's TAK Position: Q2 2026 in Review

Sanctuary Advisors increased its Takeda Pharmaceutical (TAK) stake by 25% in Q2 2026, buying an estimated $123K and bringing the position to 36,883 shares worth $591K. The position accounts for ﹤0.01% of the portfolio, ranked #1852.

Sanctuary Advisors first reported a position in TAK in Q2 2024 and has held it in 9 quarters since. The position peaked at $937K in Q3 2024. 376 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Sanctuary Advisors held 36,883 shares of Takeda Pharmaceutical worth $591K as of Q2 2026.
Sanctuary Advisors bought 7,426 Takeda Pharmaceutical shares in Q2 2026, an estimated $123K.
Takeda Pharmaceutical made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1852 holding.
Sanctuary Advisors first reported a position in Takeda Pharmaceutical in Q2 2024 and has held it in 9 quarters since.
Sanctuary Advisors's Takeda Pharmaceutical position peaked at $937K in Q3 2024.
376 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.